RA Capital Management’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,131,775
| Closed | -$19.4M | – | 58 |
|
|
2023
Q1 | $19.4M | Sell |
1,131,775
-1,275,374
| -53% | -$21.8M | 0.44% | 46 |
|
|
2022
Q4 | $47.1M | Buy |
2,407,149
+300,000
| +14% | +$5.87M | 0.96% | 33 |
|
|
2022
Q3 | $33.6M | Hold |
2,107,149
| – | – | 0.72% | 43 |
|
|
2022
Q2 | $29M | Hold |
2,107,149
| – | – | 0.77% | 38 |
|
|
2022
Q1 | $33.4M | Hold |
2,107,149
| – | – | 0.73% | 42 |
|
|
2021
Q4 | $46M | Hold |
2,107,149
| – | – | 0.81% | 36 |
|
|
2021
Q3 | $63M | Hold |
2,107,149
| – | – | 0.87% | 34 |
|
|
2021
Q2 | $93.3M | Hold |
2,107,149
| – | – | 1.5% | 18 |
|
|
2021
Q1 | $93.5M | Sell |
2,107,149
-28,932
| -1% | -$1.28M | 1.41% | 20 |
|
|
2020
Q4 | $117M | Buy |
+2,136,081
| New | +$117M | 1.64% | 17 |
|